Last 12 months
Inside the activity.
2 purchase rows · 31 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 1 | 1 |
| Jan 2026 | 0 | 7 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 10 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 24, 2025 Filed Feb 26, 2025 21:35 UTC |
Mazzariello GinaChief Legal Officer
|
SaleCommon Stock | 4,169 | $3.15 | $13,144.86 |
DisclosureSEC source: 0000950170-25-027833 · ownership.xml · nonDerivative · entry 1 Mazzariello Gina · CIK 0001913765 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,921 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.14 to $3.18. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 01:17 UTC |
Klee Justin B.Director · Co-Chief Executive Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 36,310 | $0.00 Strike: $1.57 | $0.00 |
DisclosureSEC source: 0000950170-25-015701 · ownership.xml · derivative · entry 2 Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,310 shares Expires 2025-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 01:17 UTC |
Klee Justin B.Director · Co-Chief Executive Officer
|
Exercise / conversionCommon Stock | 36,310 | $1.57 | $57,006.70 |
DisclosureSEC source: 0000950170-25-015701 · ownership.xml · nonDerivative · entry 1 Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,201,243 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:55 UTC |
Cohen Joshua BDirector · Co-Chief Executive Officer
|
SaleCommon Stock | 11,851 | $3.47 | $41,107.56 |
DisclosureSEC source: 0000950170-25-014610 · ownership.xml · nonDerivative · entry 1 Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,201,247 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.46 to $3.58. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:54 UTC |
Klee Justin B.Director · Co-Chief Executive Officer
|
SaleCommon Stock | 11,855 | $3.47 | $41,103.66 |
DisclosureSEC source: 0000950170-25-014607 · ownership.xml · nonDerivative · entry 1 Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,164,933 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.46 to $3.56. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:58 UTC |
Mazzariello GinaChief Legal Officer
|
SaleCommon Stock | 3,678 | $3.49 | $12,839.16 |
DisclosureSEC source: 0000950170-25-014620 · ownership.xml · nonDerivative · entry 1 Mazzariello Gina · CIK 0001913765 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,090 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.46 to $3.56. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| January 24, 2025 Filed Jan 28, 2025 21:55 UTC |
MILNE GEORGE M JRDirector
|
GiftCommon Stock | 27,910 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-009913 · ownership.xml · nonDerivative · entry 1 MILNE GEORGE M JR · CIK 0001179552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 830,661 F1 · kind: Represents a bona fide gift for no consideration. F2 · shares: These shares of common stock remain subject to a lock-up agreement pursuant to which they cannot be sold prior to March 11, 2025 without the consent of Leerink Partners LLC, subject to certain exceptions. Read SEC document |
| January 06, 2025 Filed Jan 8, 2025 22:26 UTC |
Cohen Joshua BDirector · Co-Chief Executive Officer
|
SaleCommon Stock | 7,471 | $4.05 | $30,232.15 |
DisclosureSEC source: 0000950170-25-003531 · ownership.xml · nonDerivative · entry 1 Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,213,098 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.99 to $4.09. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| January 06, 2025 Filed Jan 8, 2025 22:29 UTC |
Klee Justin B.Director · Co-Chief Executive Officer
|
SaleCommon Stock | 7,471 | $4.04 | $30,201.52 |
DisclosureSEC source: 0000950170-25-003533 · ownership.xml · nonDerivative · entry 1 Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,176,788 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.99 to $4.09. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 22:21 UTC |
Bedrosian Camille LChief Medical Officer
|
SaleCommon Stock | 5,421 | $5.54 | $30,007.40 |
DisclosureSEC source: 0000950170-24-132885 · ownership.xml · nonDerivative · entry 1 Bedrosian Camille L · CIK 0001326969 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,380 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.475 to $5.59. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| November 04, 2024 Filed Nov 7, 2024 00:24 UTC |
Klee Justin B.Director · Co-Chief Executive Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 63,690 | $0.00 Strike: $1.57 | $0.00 |
DisclosureSEC source: 0000950170-24-122640 · ownership.xml · derivative · entry 2 Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,310 Underlying: Common Stock · 63,690 shares Expires 2025-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| November 04, 2024 Filed Nov 7, 2024 00:24 UTC |
Klee Justin B.Director · Co-Chief Executive Officer
|
Exercise / conversionCommon Stock | 63,690 | $1.57 | $99,993.30 |
DisclosureSEC source: 0000950170-24-122640 · ownership.xml · nonDerivative · entry 1 Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,184,259 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 22:53 UTC |
Cohen Joshua BDirector · Co-Chief Executive Officer
|
SaleCommon Stock | 18,589 | $3.20 | $59,414.16 |
DisclosureSEC source: 0000950170-24-111811 · ownership.xml · nonDerivative · entry 1 Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,220,569 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.12 to $3.24. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 22:53 UTC |
Klee Justin B.Director · Co-Chief Executive Officer
|
SaleCommon Stock | 18,589 | $3.20 | $59,429.03 |
DisclosureSEC source: 0000950170-24-111812 · ownership.xml · nonDerivative · entry 1 Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,120,569 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.145 to $3.245. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 22:50 UTC |
Bedrosian Camille LChief Medical Officer
|
SaleCommon Stock | 11,442 | $3.20 | $36,559.48 |
DisclosureSEC source: 0000950170-24-111809 · ownership.xml · nonDerivative · entry 1 Bedrosian Camille L · CIK 0001326969 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,801 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.125 to $3.24. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 22:48 UTC |
Mazzariello GinaChief Legal Officer
|
SaleCommon Stock | 8,709 | $3.20 | $27,840.06 |
DisclosureSEC source: 0000950170-24-111805 · ownership.xml · nonDerivative · entry 1 Mazzariello Gina · CIK 0001913765 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,768 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.12 to $3.235. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 23, 2024 Filed Sep 25, 2024 21:56 UTC |
Cohen Joshua BDirector · Co-Chief Executive Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,857 | $0.00 Strike: $1.57 | $0.00 |
DisclosureSEC source: 0000950170-24-109397 · ownership.xml · derivative · entry 2 Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,857 shares Expires 2025-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| September 23, 2024 Filed Sep 25, 2024 21:56 UTC |
Cohen Joshua BDirector · Co-Chief Executive Officer
|
Exercise / conversionCommon Stock | 1,857 | $1.57 | $2,915.49 |
DisclosureSEC source: 0000950170-24-109397 · ownership.xml · nonDerivative · entry 1 Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,239,158 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2024 Filed Sep 16, 2024 21:39 UTC |
Cohen Joshua BDirector · Co-Chief Executive Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 34,449 | $0.00 Strike: $1.57 | $0.00 |
DisclosureSEC source: 0000950170-24-106915 · ownership.xml · derivative · entry 2 Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,857 Underlying: Common Stock · 34,449 shares Expires 2025-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| September 12, 2024 Filed Sep 16, 2024 21:39 UTC |
Cohen Joshua BDirector · Co-Chief Executive Officer
|
Exercise / conversionCommon Stock | 34,449 | $1.57 | $54,084.93 |
DisclosureSEC source: 0000950170-24-106915 · ownership.xml · nonDerivative · entry 1 Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,237,301 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2024 Filed Sep 16, 2024 21:30 UTC |
FRATES JAMES MChief Financial Officer
|
PurchaseCommon Stock | 40,000 | $2.53 | $101,368.00 |
DisclosureSEC source: 0000950170-24-106910 · ownership.xml · nonDerivative · entry 1 FRATES JAMES M · CIK 0001235598 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 233,464 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.4849 to $2.63. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:05 UTC |
Firestone KarenDirector
|
PurchaseCommon Stock | 50,000 | $2.13 | $106,590.00 |
DisclosureSEC source: 0000950170-24-104737 · ownership.xml · nonDerivative · entry 1 Firestone Karen · CIK 0001969821 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,000 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.11 to $2.15. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 23:26 UTC |
MILNE GEORGE M JRDirector
|
PurchaseCommon Stock | 100,000 | $2.20 | $219,800.00 |
DisclosureSEC source: 0000950170-24-104186 · ownership.xml · nonDerivative · entry 1 MILNE GEORGE M JR · CIK 0001179552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 858,571 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.14 to $2.235. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 20:44 UTC |
MILNE GEORGE M JRDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0000950170-24-070778 · ownership.xml · derivative · entry 1 MILNE GEORGE M JR · CIK 0001179552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2034-06-05 F1 · derivative.exercise_date: The shares subject to this option shall vest in full upon the earlier of (i) June 6, 2025 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 16:49 UTC |
Zeiher Bernhardt GDirector
|
GrantStock Option (right to buy) · Derivative | 5,753 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0000950170-24-070797 · ownership.xml · derivative · entry 1 Zeiher Bernhardt G · CIK 0001971421 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,753 Underlying: Common Stock · 5,753 shares Expires 2034-06-05 F1 · derivative.exercise_date: The shares subject to this option shall vest in full upon the earlier of (i) June 6, 2025 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 20:52 UTC |
FONTEYNE PAUL R.Director
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0000950170-24-070811 · ownership.xml · derivative · entry 1 FONTEYNE PAUL R. · CIK 0001727550 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2034-06-05 F1 · derivative.exercise_date: The shares subject to this option shall vest in full upon the earlier of (i) June 6, 2025 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 20:50 UTC |
Firestone KarenDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0000950170-24-070804 · ownership.xml · derivative · entry 1 Firestone Karen · CIK 0001969821 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2034-06-05 F1 · derivative.exercise_date: The shares subject to this option shall vest in full upon the earlier of (i) June 6, 2025 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 20:42 UTC |
Quimi DaphneDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0000950170-24-070769 · ownership.xml · derivative · entry 1 Quimi Daphne · CIK 0001543031 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2034-06-05 F1 · derivative.exercise_date: The shares subject to this option shall vest in full upon the earlier of (i) June 6, 2025 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| May 15, 2024 Filed May 16, 2024 23:37 UTC |
Quimi DaphneDirector
|
PurchaseCommon Stock | 2,250 | $1.89 | $4,252.28 |
DisclosureSEC source: 0000950170-24-061294 · ownership.xml · nonDerivative · entry 2 Quimi Daphne · CIK 0001543031 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Read SEC document |
| May 15, 2024 Filed May 16, 2024 23:36 UTC |
Mazzariello GinaChief Legal Officer
|
SaleCommon Stock | 10,455 | $1.88 | $19,654.35 |
DisclosureSEC source: 0000950170-24-061293 · ownership.xml · nonDerivative · entry 1 Mazzariello Gina · CIK 0001913765 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 151,477 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2023. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.82 to $1.92. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 14, 2024 Filed May 16, 2024 23:37 UTC |
Quimi DaphneDirector
|
PurchaseCommon Stock | 2,750 | $1.89 | $5,183.75 |
DisclosureSEC source: 0000950170-24-061294 · ownership.xml · nonDerivative · entry 1 Quimi Daphne · CIK 0001543031 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,750 Read SEC document |
| April 16, 2024 Filed Apr 19, 2024 00:21 UTC |
Cohen Joshua BDirector · Co-Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 380,000 | $0.00 Strike: $2.01 | $0.00 |
DisclosureSEC source: 0000950170-24-045696 · ownership.xml · derivative · entry 2 Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 380,000 Underlying: Common Stock · 380,000 shares Expires 2034-04-15 F2 · derivative.exercise_date: 25% of the shares subject to the option shall vest and become exercisable on April 16, 2025, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. Read SEC document |
| April 16, 2024 Filed Apr 19, 2024 00:21 UTC |
Cohen Joshua BDirector · Co-Chief Executive Officer
|
GrantCommon Stock | 179,850 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-045696 · ownership.xml · nonDerivative · entry 1 Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,202,852 F1 · shares: The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSUs shall vest as follows: 33% on September 30, 2024, 33% on March 31, 2025 and 34% on September 30, 2025, subject to the Reporting Person's continued service to the Issuer through each such vesting date. Read SEC document |
| April 16, 2024 Filed Apr 19, 2024 00:20 UTC |
Klee Justin B.Director · Co-Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 380,000 | $0.00 Strike: $2.01 | $0.00 |
DisclosureSEC source: 0000950170-24-045694 · ownership.xml · derivative · entry 2 Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 380,000 Underlying: Common Stock · 380,000 shares Expires 2034-04-15 F2 · derivative.exercise_date: 25% of the shares subject to the option shall vest and become exercisable on April 16, 2025, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. Read SEC document |
| April 16, 2024 Filed Apr 19, 2024 00:20 UTC |
Klee Justin B.Director · Co-Chief Executive Officer
|
GrantCommon Stock | 179,850 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-045694 · ownership.xml · nonDerivative · entry 1 Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,139,158 F1 · shares: The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSUs shall vest as follows: 33% on September 30, 2024, 33% on March 31, 2025 and 34% on September 30, 2025, subject to the Reporting Person's continued service to the Issuer through each such vesting date. Read SEC document |
| April 16, 2024 Filed Apr 19, 2024 00:19 UTC |
Bedrosian Camille LChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 120,000 | $0.00 Strike: $2.01 | $0.00 |
DisclosureSEC source: 0000950170-24-045693 · ownership.xml · derivative · entry 2 Bedrosian Camille L · CIK 0001326969 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2034-04-15 F2 · derivative.exercise_date: 25% of the shares subject to the option shall vest and become exercisable on April 16, 2025, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. Read SEC document |
| April 16, 2024 Filed Apr 19, 2024 00:19 UTC |
Bedrosian Camille LChief Medical Officer
|
GrantCommon Stock | 96,910 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-045693 · ownership.xml · nonDerivative · entry 1 Bedrosian Camille L · CIK 0001326969 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,243 F1 · shares: The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSUs shall vest as follows: 33% on September 30, 2024, 33% on March 31, 2025 and 34% on September 30, 2025, subject to the Reporting Person's continued service to the Issuer through each such vesting date. Read SEC document |
| April 16, 2024 Filed Apr 19, 2024 00:23 UTC |
FRATES JAMES MChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 120,000 | $0.00 Strike: $2.01 | $0.00 |
DisclosureSEC source: 0000950170-24-045698 · ownership.xml · derivative · entry 4 FRATES JAMES M · CIK 0001235598 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2034-04-15 F4 · derivative.exercise_date: 25% of the shares subject to the option shall vest and become exercisable on April 16, 2025, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. Read SEC document |
| April 16, 2024 Filed Apr 19, 2024 00:23 UTC |
FRATES JAMES MChief Financial Officer
|
GrantCommon Stock | 91,180 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-045698 · ownership.xml · nonDerivative · entry 1 FRATES JAMES M · CIK 0001235598 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,964 F1 · shares: The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSUs shall vest as follows: 33% on September 30, 2024, 33% on March 31, 2025 and 34% on September 30, 2025, subject to the Reporting Person's continued service to the Issuer through each such vesting date. Read SEC document |
| April 16, 2024 Filed Apr 19, 2024 00:20 UTC |
Mazzariello GinaChief Legal Officer
|
GrantStock Option (right to buy) · Derivative | 110,000 | $0.00 Strike: $2.01 | $0.00 |
DisclosureSEC source: 0000950170-24-045695 · ownership.xml · derivative · entry 2 Mazzariello Gina · CIK 0001913765 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock · 110,000 shares Expires 2034-04-15 F2 · derivative.exercise_date: 25% of the shares subject to the option shall vest and become exercisable on April 16, 2025, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. Read SEC document |
| April 16, 2024 Filed Apr 19, 2024 00:20 UTC |
Mazzariello GinaChief Legal Officer
|
GrantCommon Stock | 80,560 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-045695 · ownership.xml · nonDerivative · entry 1 Mazzariello Gina · CIK 0001913765 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,932 F1 · shares: The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSUs shall vest as follows: 33% on September 30, 2024, 33% on March 31, 2025 and 34% on September 30, 2025, subject to the Reporting Person's continued service to the Issuer through each such vesting date. Read SEC document |
| March 14, 2024 Filed Mar 15, 2024 16:35 UTC |
Zeiher Bernhardt GDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $3.17 | $0.00 |
DisclosureSEC source: 0000950170-24-032246 · ownership.xml · derivative · entry 1 Zeiher Bernhardt G · CIK 0001971421 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2034-03-13 F1 · derivative.exercise_date: One-third of the shares subject to the option shall vest on the first anniversary of the date of grant, and the remaining two-thirds will vest in equal monthly installments over two years, provided, however, that all vesting shall cease if the director resigns from the Board or otherwise ceases to serve as a director of the Issuer. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 21:05 UTC |
Cohen Joshua BDirector · Co-Chief Executive Officer
|
SaleCommon Stock | 4,135 | $18.73 | $77,439.87 |
DisclosureSEC source: 0000950170-24-027923 · ownership.xml · nonDerivative · entry 1 Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,023,002 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.62 to $18.82. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 21:05 UTC |
Klee Justin B.Director · Co-Chief Executive Officer
|
SaleCommon Stock | 4,135 | $18.73 | $77,439.87 |
DisclosureSEC source: 0000950170-24-027922 · ownership.xml · nonDerivative · entry 1 Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,959,308 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.62 to $18.82. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 21:05 UTC |
FRATES JAMES MChief Financial Officer
|
SaleCommon Stock | 1,792 | $18.73 | $33,560.40 |
DisclosureSEC source: 0000950170-24-027918 · ownership.xml · nonDerivative · entry 1 FRATES JAMES M · CIK 0001235598 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,784 F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.62 to $18.82. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 21:05 UTC |
Mazzariello GinaChief Legal Officer
|
SaleCommon Stock | 1,540 | $18.73 | $28,840.97 |
DisclosureSEC source: 0000950170-24-027921 · ownership.xml · nonDerivative · entry 1 Mazzariello Gina · CIK 0001913765 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,372 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.62 to $18.82. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 23:22 UTC |
Cohen Joshua BDirector · Co-Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 190,000 | $0.00 Strike: $17.56 | $0.00 |
DisclosureSEC source: 0000950170-24-022413 · ownership.xml · derivative · entry 2 Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 190,000 Underlying: Common Stock · 190,000 shares Expires 2034-02-25 F2 · derivative.exercise_date: 1/4 of the shares subject to the option shall vest and become exercisable on the first day of the month of the one year anniversary of the date of grant, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 23:22 UTC |
Cohen Joshua BDirector · Co-Chief Executive Officer
|
GrantCommon Stock | 126,667 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-022413 · ownership.xml · nonDerivative · entry 1 Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,027,137 F1 · shares: The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSU shall vest in 4 equal annual installments, with the first installment vesting on the first day of the month of the one year anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 23:20 UTC |
Klee Justin B.Director · Co-Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 190,000 | $0.00 Strike: $17.56 | $0.00 |
DisclosureSEC source: 0000950170-24-022410 · ownership.xml · derivative · entry 2 Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 190,000 Underlying: Common Stock · 190,000 shares Expires 2034-02-25 F2 · derivative.exercise_date: 1/4 of the shares subject to the option shall vest and become exercisable on the first day of the month of the one year anniversary of the date of grant, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 23:20 UTC |
Klee Justin B.Director · Co-Chief Executive Officer
|
GrantCommon Stock | 126,667 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-022410 · ownership.xml · nonDerivative · entry 1 Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,963,443 F1 · shares: The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSU shall vest in 4 equal annual installments, with the first installment vesting on the first day of the month of the one year anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.